annual accounts payable:
$110.00M-$23.30M(-17.48%)Summary
- As of today (May 29, 2025), NBIX annual accounts payable is $110.00 million, with the most recent change of -$23.30 million (-17.48%) on December 31, 2024.
- During the last 3 years, NBIX annual accounts payable has risen by +$58.50 million (+113.59%).
- NBIX annual accounts payable is now -17.48% below its all-time high of $133.30 million, reached on December 31, 2023.
Performance
NBIX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$110.00M$0.00(0.00%)Summary
- As of today (May 29, 2025), NBIX quarterly accounts payable is $110.00 million, unchanged on March 31, 2025.
- Over the past year, NBIX quarterly accounts payable has increased by +$22.70 million (+26.00%).
- NBIX quarterly accounts payable is now -17.48% below its all-time high of $133.30 million, reached on December 31, 2023.
Performance
NBIX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NBIX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.5% | +26.0% |
| 3 y3 years | +113.6% | - |
| 5 y5 years | +165.7% | - |
NBIX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.5% | +113.6% | -17.5% | +63.5% |
| 5 y | 5-year | -17.5% | +179.2% | -17.5% | +179.2% |
| alltime | all time | -17.5% | >+9999.0% | -17.5% | >+9999.0% |
NBIX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $110.00M(0.0%) |
| Dec 2024 | $110.00M(-17.5%) | $110.00M(+14.9%) |
| Sep 2024 | - | $95.70M(-10.7%) |
| Jun 2024 | - | $107.20M(+22.8%) |
| Mar 2024 | - | $87.30M(-34.5%) |
| Dec 2023 | $133.30M(+98.1%) | $133.30M(+42.1%) |
| Sep 2023 | - | $93.80M(+39.4%) |
| Dec 2022 | $67.30M(+30.7%) | $67.30M(+30.7%) |
| Dec 2021 | $51.50M(+30.7%) | $51.50M(+30.7%) |
| Dec 2020 | $39.40M(-4.8%) | $39.40M(-4.8%) |
| Dec 2019 | $41.40M(+7.9%) | $41.40M(+7.9%) |
| Dec 2018 | $38.38M(+579.6%) | $38.38M(+579.6%) |
| Dec 2017 | $5.65M(+11.1%) | $5.65M(+562.9%) |
| Mar 2017 | - | $852.00K(-83.2%) |
| Dec 2016 | $5.08M(+98.6%) | $5.08M(+195.8%) |
| Sep 2016 | - | $1.72M(-2.4%) |
| Jun 2016 | - | $1.76M(-17.0%) |
| Mar 2016 | - | $2.12M(-17.1%) |
| Dec 2015 | $2.56M(+941.1%) | $2.56M(+114.0%) |
| Sep 2015 | - | $1.20M(+15.7%) |
| Jun 2015 | - | $1.03M(-18.5%) |
| Mar 2015 | - | $1.27M(+416.3%) |
| Dec 2014 | $246.00K(+143.6%) | $246.00K(-72.7%) |
| Sep 2014 | - | $900.00K(+6.4%) |
| Jun 2014 | - | $846.00K(+3.4%) |
| Mar 2014 | - | $818.00K(+709.9%) |
| Dec 2013 | $101.00K(-88.9%) | $101.00K(-90.8%) |
| Sep 2013 | - | $1.10M(-18.6%) |
| Jun 2013 | - | $1.35M(-7.7%) |
| Mar 2013 | - | $1.46M(+60.3%) |
| Dec 2012 | $911.00K(-18.0%) | $911.00K(-35.7%) |
| Sep 2012 | - | $1.42M(-0.3%) |
| Jun 2012 | - | $1.42M(+138.3%) |
| Mar 2012 | - | $596.00K(-46.4%) |
| Dec 2011 | $1.11M(+37.2%) | $1.11M(+45.0%) |
| Sep 2011 | - | $766.00K(-17.8%) |
| Jun 2011 | - | $932.00K(+83.8%) |
| Mar 2011 | - | $507.00K(-37.4%) |
| Dec 2010 | $810.00K(-63.0%) | $810.00K(-11.2%) |
| Sep 2010 | - | $912.00K(+42.5%) |
| Jun 2010 | - | $640.00K(+18.7%) |
| Mar 2010 | - | $539.00K(-75.4%) |
| Dec 2009 | $2.19M(+36.8%) | $2.19M(+45.8%) |
| Sep 2009 | - | $1.50M(-14.3%) |
| Jun 2009 | - | $1.75M(-31.3%) |
| Mar 2009 | - | $2.55M(+59.5%) |
| Dec 2008 | $1.60M | $1.60M(-46.5%) |
| Sep 2008 | - | $2.99M(+9.1%) |
| Jun 2008 | - | $2.74M(+94.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.41M(-62.7%) |
| Dec 2007 | $3.78M(+17.5%) | $3.78M(-78.2%) |
| Sep 2007 | - | $17.29M(+10.4%) |
| Jun 2007 | - | $15.66M(+12.6%) |
| Mar 2007 | - | $13.91M(+332.9%) |
| Dec 2006 | $3.21M(-84.9%) | $3.21M(-79.2%) |
| Sep 2006 | - | $15.43M(-10.5%) |
| Jun 2006 | - | $17.23M(+2.6%) |
| Mar 2006 | - | $16.79M(-21.3%) |
| Dec 2005 | $21.34M(+295.9%) | $21.34M(+18.0%) |
| Sep 2005 | - | $18.09M(+2.1%) |
| Jun 2005 | - | $17.72M(-5.4%) |
| Mar 2005 | - | $18.73M(+247.5%) |
| Dec 2004 | $5.39M(+316.3%) | $5.39M(-81.8%) |
| Sep 2004 | - | $29.57M(+9.0%) |
| Jun 2004 | - | $27.12M(+831.9%) |
| Mar 2004 | - | $2.91M(+124.7%) |
| Dec 2003 | $1.29M(-33.9%) | $1.29M(-32.3%) |
| Sep 2003 | - | $1.91M(-29.6%) |
| Jun 2003 | - | $2.72M(+25.6%) |
| Mar 2003 | - | $2.16M(+10.4%) |
| Dec 2002 | $1.96M(+27.3%) | $1.96M(-46.6%) |
| Sep 2002 | - | $3.67M(+153.9%) |
| Jun 2002 | - | $1.45M(+66.5%) |
| Mar 2002 | - | $868.00K(-43.6%) |
| Dec 2001 | $1.54M(+44.5%) | $1.54M(+13.7%) |
| Sep 2001 | - | $1.35M(+85.2%) |
| Jun 2001 | - | $731.00K(+11.1%) |
| Mar 2001 | - | $658.00K(-38.2%) |
| Dec 2000 | $1.06M(-55.6%) | $1.06M(+36.0%) |
| Sep 2000 | - | $783.00K(+11.9%) |
| Jun 2000 | - | $700.00K(-59.8%) |
| Mar 2000 | - | $1.74M(-27.5%) |
| Dec 1999 | $2.40M(-4.0%) | $2.40M(+200.0%) |
| Sep 1999 | - | $800.00K(-33.3%) |
| Jun 1999 | - | $1.20M(+71.4%) |
| Mar 1999 | - | $700.00K(-72.0%) |
| Dec 1998 | $2.50M(+38.9%) | $2.50M(+127.3%) |
| Sep 1998 | - | $1.10M(+83.3%) |
| Jun 1998 | - | $600.00K(+20.0%) |
| Mar 1998 | - | $500.00K(-72.2%) |
| Dec 1997 | $1.80M(+125.0%) | $1.80M(+5.9%) |
| Sep 1997 | - | $1.70M(+240.0%) |
| Jun 1997 | - | $500.00K(-44.4%) |
| Mar 1997 | - | $900.00K(+12.5%) |
| Dec 1996 | $800.00K | $800.00K(+33.3%) |
| Sep 1996 | - | $600.00K(-45.5%) |
| Jun 1996 | - | $1.10M(+450.0%) |
| Mar 1996 | - | $200.00K |
FAQ
- What is Neurocrine Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual accounts payable year-on-year change?
- What is Neurocrine Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly accounts payable year-on-year change?
What is Neurocrine Biosciences annual accounts payable?
The current annual accounts payable of NBIX is $110.00M
What is the all time high annual accounts payable for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual accounts payable is $133.30M
What is Neurocrine Biosciences annual accounts payable year-on-year change?
Over the past year, NBIX annual accounts payable has changed by -$23.30M (-17.48%)
What is Neurocrine Biosciences quarterly accounts payable?
The current quarterly accounts payable of NBIX is $110.00M
What is the all time high quarterly accounts payable for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly accounts payable is $133.30M
What is Neurocrine Biosciences quarterly accounts payable year-on-year change?
Over the past year, NBIX quarterly accounts payable has changed by +$22.70M (+26.00%)